Progyny, Inc. (NASDAQ:PGNY) Shares Bought by Arizona State Retirement System

Arizona State Retirement System increased its stake in Progyny, Inc. (NASDAQ:PGNY – Get Rating) by 4.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,786 shares of the company’s stock after purchasing an additional 797 shares during the period. Arizona State Retirement System’s holdings in Progyny were worth $647,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Lazard Asset Management LLC acquired a new stake in Progyny during the 1st quarter valued at approximately $62,000. Parkside Financial Bank & Trust acquired a new stake in Progyny during the 1st quarter valued at approximately $70,000. Nisa Investment Advisors LLC lifted its stake in Progyny by 390.4% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,207 shares of the company’s stock valued at $97,000 after acquiring an additional 1,757 shares during the period. Captrust Financial Advisors lifted its stake in Progyny by 25.0% during the 1st quarter. Captrust Financial Advisors now owns 2,091 shares of the company’s stock valued at $107,000 after acquiring an additional 418 shares during the period. Finally, B. Riley Wealth Advisors Inc. acquired a new stake in Progyny during the 3rd quarter valued at approximately $201,000. 86.12% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Chairman David J. Schlanger sold 41,667 shares of the business’s stock in a transaction on Thursday, March 2nd. The shares were sold at an average price of $36.11, for a total value of $1,504,595.37. Following the completion of the sale, the chairman now owns 76,168 shares of the company’s stock, valued at approximately $2,750,426.48. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, CEO Peter Anevski sold 1,857 shares of the company’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $35.00, for a total transaction of $64,995.00. Following the completion of the sale, the chief executive officer now owns 215,924 shares of the company’s stock, valued at $7,557,340. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman David J. Schlanger sold 41,667 shares of the company’s stock in a transaction on Thursday, March 2nd. The stock was sold at an average price of $36.11, for a total transaction of $1,504,595.37. Following the sale, the chairman now directly owns 76,168 shares of the company’s stock, valued at approximately $2,750,426.48. The disclosure for this sale can be found here. In the last quarter, insiders sold 352,826 shares of company stock valued at $12,704,041. 14.00% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Cantor Fitzgerald lifted their price objective on shares of Progyny from $44.00 to $45.00 in a research note on Tuesday, May 9th. Bank of America boosted their target price on shares of Progyny from $48.00 to $50.00 in a research note on Tuesday, May 9th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $48.67.

Progyny Stock Performance

Shares of NASDAQ PGNY opened at $35.49 on Thursday. The firm has a market cap of $3.35 billion, a PE ratio of 82.53, a PEG ratio of 2.13 and a beta of 1.51. The firm has a fifty day moving average of $33.36 and a 200 day moving average of $33.69. Progyny, Inc. has a one year low of $25.67 and a one year high of $46.50.

Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings results on Monday, May 8th. The company reported $0.18 EPS for the quarter, topping the consensus estimate of $0.08 by $0.10. The company had revenue of $258.40 million during the quarter, compared to analyst estimates of $246.63 million. Progyny had a net margin of 4.93% and a return on equity of 11.81%. The firm’s revenue was up 50.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.05 EPS. On average, equities analysts predict that Progyny, Inc. will post 0.44 EPS for the current fiscal year.

About Progyny

(Get Rating)

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.